Artemis Medicare Services Ltd (ARTEMISMED) — shareholding pattern, promoter holding, financials and share price
About Artemis Medicare Services Ltd (ARTEMISMED)
Artemis Medicare Services Ltd operates in the Hospital industry, within the Healthcare sector. It trades on the NSE as ARTEMISMED and on the BSE under scrip code 542919. Its ISIN is INE025R01021.
Artemis Medicare Services Ltd (AMSL) was incorporated in 2004, operates a 541-bedded multi-specialty tertiary care hospital in Gurgaon. [1] [2]
Artemis Hospitals operates as a leading multi-speciality healthcare provider located in Gurugram, India, offering a wide range of medical services. They aim to increase their total bed capacity significantly to 2,300 beds by 2029 through strategic expansions, including new hospital setups. Artemis Hospitals has achieved substantial growth in international patient revenue, contributing significantly to total revenue, reflecting its strong positioning in medical tourism.
The hospital is recognized for its advanced technological adoption, including the use of AI-assisted triage systems and cutting-edge medical equipment like Da Vinci® Robotic Surgical System. This technological edge supports enhanced patient care and operational efficiency.
Listed peers in Hospital: Kovai Medical Center & Hospital Ltd, Indraprastha Medical Corporation Ltd, Dr Agarwals Eye Hospital Ltd, KMC Speciality Hospitals (India) Ltd, Shalby Ltd, Unihealth Hospitals Ltd.
Valuation & Returns
10 Jul 2026At ₹275.5 a share on 10 Jul 2026, Artemis Medicare Services Ltd (ARTEMISMED) was valued at a price-to-earnings ratio of 42.05x against an industry P/E of 61.73x and a price-to-book of 4.67x on a book value of ₹59.04 per share as of Mar 2026. Solomo computes return on equity of 11.1% and return on capital employed of 13.95% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 42.05x
- Industry P/E
- 61.73x
- P/B
- 4.67x
- EPS (TTM)
- ₹6.55
- Book value / share
- ₹59.04
- ROE
- 11.1%
- ROCE
- 13.95%
- ROA
- 7.26%
- Debt / equity
- 0.28x
- Dividend yield
- 0.33%
- EBITDA margin
- 19.88%
- 52-week range
- ₹202.85 – ₹297.7
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Artemis Medicare Services Ltd (ARTEMISMED) reported revenue of ₹1,081 crore, net profit of ₹104 crore and earnings per share of ₹6.55. That compares with revenue of ₹937 crore and net profit of ₹82 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹279 crore and net profit ₹30 crore (consolidated).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 555 | 737 | 879 | 937 | 1,081 |
| Net profit (₹ cr) | 31 | 38 | 49 | 82 | 104 |
| EPS (₹) | 2.4 | 2.88 | 3.62 | 6 | 6.55 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 9.75% | 21.41% | 14.08% | 15.40% |
| Profit growth | 16.06% | 70.94% | 37.62% | 26.21% |
| Stock price CAGR | - | 50% | 31% | 10% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 58.39% of Artemis Medicare Services Ltd (ARTEMISMED) (unchanged from the previous quarter), foreign institutional investors (FII) hold 12.29% and domestic institutional investors (DII) hold 2.4%. Market capitalisation was ₹4,361 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Dec 2019.
Largest disclosed public shareholders in Jun 2026: INTERNATIONAL FINANCE CORPORATION 11.98%, GOVERNOR OF KERALA 4.26%, DEVLINA CHAKRAVARTY 2.92%, KERALA STATE INDUSTRIAL DEVELOPMENT CORPORATION 1.9%, Unclaimed or Suspense or Escrow Account 1.48%, ARTEMIS MEDICARE SERVICES LIMITED-UNCLAIMED SUSPENSE ACCOUNT 1.48%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 58.39% | - | 12.29% | 2.4% | 41.61% |
| Mar 2026 | 58.39% | - | 12.19% | 2.89% | 41.61% |
| Dec 2025 | 58.39% | - | 12.47% | 2.91% | 41.61% |
| Sep 2025 | 66.53% | - | 0.37% | 4.27% | 33.47% |
| Jun 2025 | 66.53% | - | 0.24% | 4.76% | 33.47% |
| Mar 2025 | 67.17% | 44.5% | 0.31% | 5.04% | 32.83% |
| Dec 2024 | 67.17% | 44.5% | 0.64% | 4.5% | 32.83% |
| Sep 2024 | 67.17% | 44.5% | 0.22% | 3.6% | 32.83% |